<?xml version="1.0" encoding="UTF-8"?>
<p id="p0140">In conclusion, evidence of the possible use of baricitinib in the treatment of COVID-19 infection remains highly controversial and further studies are warranted to better clarify its potential role in the treatment of more serious cases of viral pneumonia.</p>
